Quarterly report [Sections 13 or 15(d)]

Consolidated Statements of Cash Flows

v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net income $ (3,412) $ 668
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, amortization and accretion expense 373 312
Share-based compensation expense 78 56
Amortization of discount and debt issuance costs 10 9
Reduction of right-of-use assets 145 159
Total losses on derivative instruments, net 5,457 539
Net cash provided by (used for) settlement of derivative instruments (509) 71
Deferred taxes (385) 38
Other, net 31 (14)
Changes in operating assets and liabilities:    
Trade and other receivables 179 (286)
Inventory (156) (24)
Margin deposits (213) 41
Other non-current assets 65 (21)
Accounts payable and accrued liabilities (131) (93)
Total deferred revenue (45) (57)
Total operating lease liabilities (145) (152)
Other non-current liabilities (216) 0
Other, net (46) (18)
Net cash provided by operating activities 1,080 1,228
Cash flows from investing activities    
Property, plant and equipment, net of proceeds from commissioning sales of LNG of $42 million and $43 million, respectively (736) (623)
Proceeds from sale of equity method investment 0 80
Other, net (6) (6)
Net cash used in investing activities (742) (549)
Cash flows from financing activities    
Proceeds from issuances of debt and borrowings 2,543 125
Redemptions and repayments of debt (1,603) (425)
Distributions to NCI (202) (200)
Contributions from redeemable NCI 0 38
Redemption of redeemable NCI (136) 0
Payments related to tax withholdings for share-based compensation (36) (44)
Repurchase of common stock, inclusive of excise taxes paid (537) (363)
Dividends to stockholders (117) (112)
Other, net (61) (16)
Net cash used in financing activities (149) (997)
Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents (5) (4)
Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents 184 (322)
Cash, cash equivalents and restricted cash and cash equivalents—beginning of period 1,584 3,190
Cash, cash equivalents and restricted cash and cash equivalents—end of period $ 1,768 $ 2,868